Clinical Trial Update: A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of pembrolizumab in combination with chemotherapy for head and neck squamous cell carcinoma is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Chicago | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: SUSPENDED